
A religion graduate became a banker, a pharmacy builder and then the operator behind Lumata Health. His career keeps returning to the same unglamorous question: what happens after the plan meets real life?

Long before remote care became a health-tech slogan, the Oklahoma retinal specialist put portable lasers in a vehicle and went where patients were. Lumata Health is the scaled-up version of the same stubborn idea: access is part of the treatment.

A wedding-planning startup noticed an odd stream of Pinterest traffic. Daniel Maloney followed the clue, changed the company and built Tailwind around a habit he learned at Google: watch what people do, then make the useful thing easier.

A frustrated listener asked Reddit for an IMDb of podcasts. The answer became Podchaser - and a lesson in how stubborn curiosity can turn a messy open medium into useful infrastructure.
Mohan Purushothaman is the co-founder, chairman, and CEO of Progentec Diagnostics, an Oklahoma City company building blood tests and digital tools that aim to predict autoimmune disease flares before they happen. He came to diagnostics by an unusual route: a Johns Hopkins Ph.D. focused on pharmaceutical pricing, a Harvard research fellowship, five years inside Roche, and a pricing-software practice he built and sold to Alliance Life Sciences. In 2014 he turned that commercial instinct toward lupus, partnering with the Oklahoma Medical Research Foundation, and in 2020 raised a $5M Series A led by Plains Venture Partners to bring the aiSLE DX flare-prediction platform and the LupusCorner patient community to market.